

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular response to zinc ion (GO:0071294) | 9.37007264 |
| 2 | muscle cell cellular homeostasis (GO:0046716) | 8.50343945 |
| 3 | cellular response to cadmium ion (GO:0071276) | 7.27352633 |
| 4 | arginine catabolic process (GO:0006527) | 5.68802157 |
| 5 | regulation of skeletal muscle contraction (GO:0014819) | 5.67462666 |
| 6 | regulation of integrin-mediated signaling pathway (GO:2001044) | 5.62375073 |
| 7 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 5.59331638 |
| 8 | muscle organ morphogenesis (GO:0048644) | 5.42479261 |
| 9 | positive regulation of natural killer cell differentiation (GO:0032825) | 5.06574074 |
| 10 | heart contraction (GO:0060047) | 5.06552696 |
| 11 | heart process (GO:0003015) | 5.06552696 |
| 12 | mesenchymal-epithelial cell signaling (GO:0060638) | 4.93617426 |
| 13 | actin-myosin filament sliding (GO:0033275) | 4.88803767 |
| 14 | muscle filament sliding (GO:0030049) | 4.88803767 |
| 15 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 4.70251705 |
| 16 | Rac protein signal transduction (GO:0016601) | 4.66563721 |
| 17 | response to gravity (GO:0009629) | 4.65746526 |
| 18 | fibroblast migration (GO:0010761) | 4.56809693 |
| 19 | actin-mediated cell contraction (GO:0070252) | 4.51921717 |
| 20 | striated muscle atrophy (GO:0014891) | 4.50193646 |
| 21 | multicellular organismal movement (GO:0050879) | 4.38026677 |
| 22 | musculoskeletal movement (GO:0050881) | 4.38026677 |
| 23 | behavioral response to ethanol (GO:0048149) | 4.25795978 |
| 24 | response to redox state (GO:0051775) | 4.24603797 |
| 25 | skeletal muscle adaptation (GO:0043501) | 4.21814547 |
| 26 | skeletal muscle contraction (GO:0003009) | 4.11815355 |
| 27 | regulation of chronic inflammatory response (GO:0002676) | 4.06207015 |
| 28 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.97834433 |
| 29 | skeletal muscle tissue development (GO:0007519) | 3.92892157 |
| 30 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 3.91770711 |
| 31 | response to muscle activity (GO:0014850) | 3.90998361 |
| 32 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 3.87741554 |
| 33 | neuromuscular junction development (GO:0007528) | 3.86678409 |
| 34 | muscle atrophy (GO:0014889) | 3.84741637 |
| 35 | membrane raft organization (GO:0031579) | 3.83046986 |
| 36 | barbed-end actin filament capping (GO:0051016) | 3.79752148 |
| 37 | cardiac myofibril assembly (GO:0055003) | 3.52484056 |
| 38 | positive regulation of actin filament depolymerization (GO:0030836) | 3.46928371 |
| 39 | positive regulation of tolerance induction (GO:0002645) | 3.39633816 |
| 40 | myofibril assembly (GO:0030239) | 3.39523014 |
| 41 | arginine metabolic process (GO:0006525) | 3.37110923 |
| 42 | vagina development (GO:0060068) | 3.33561103 |
| 43 | negative regulation of monooxygenase activity (GO:0032769) | 3.32320501 |
| 44 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.31386566 |
| 45 | actin filament-based movement (GO:0030048) | 3.31080868 |
| 46 | skin morphogenesis (GO:0043589) | 3.30619529 |
| 47 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.29892842 |
| 48 | regulation of the force of heart contraction (GO:0002026) | 3.26909976 |
| 49 | actin filament depolymerization (GO:0030042) | 3.24550608 |
| 50 | regulation of natural killer cell differentiation (GO:0032823) | 3.24524978 |
| 51 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.24155450 |
| 52 | membrane assembly (GO:0071709) | 3.23686405 |
| 53 | sarcomere organization (GO:0045214) | 3.20887056 |
| 54 | substrate adhesion-dependent cell spreading (GO:0034446) | 3.20591557 |
| 55 | response to cadmium ion (GO:0046686) | 3.19818604 |
| 56 | response to zinc ion (GO:0010043) | 3.17839421 |
| 57 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.12828883 |
| 58 | 4-hydroxyproline metabolic process (GO:0019471) | 3.12609888 |
| 59 | cellular response to interferon-alpha (GO:0035457) | 3.12590142 |
| 60 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 3.12221097 |
| 61 | regulation of muscle hypertrophy (GO:0014743) | 3.12093044 |
| 62 | zinc ion homeostasis (GO:0055069) | 3.08556146 |
| 63 | COPII vesicle coating (GO:0048208) | 3.08078241 |
| 64 | collagen fibril organization (GO:0030199) | 3.02743184 |
| 65 | regulation of metalloenzyme activity (GO:0048552) | 3.01092764 |
| 66 | regulation of sarcomere organization (GO:0060297) | 2.98848431 |
| 67 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.98089494 |
| 68 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.93119247 |
| 69 | muscle tissue morphogenesis (GO:0060415) | 2.90071360 |
| 70 | muscle organ development (GO:0007517) | 2.87624261 |
| 71 | negative regulation of muscle hypertrophy (GO:0014741) | 2.87080762 |
| 72 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.84969021 |
| 73 | protein hydroxylation (GO:0018126) | 2.84707974 |
| 74 | localization within membrane (GO:0051668) | 2.82513227 |
| 75 | embryonic cranial skeleton morphogenesis (GO:0048701) | 2.81051676 |
| 76 | muscle structure development (GO:0061061) | 2.80838865 |
| 77 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.80296329 |
| 78 | striated muscle tissue development (GO:0014706) | 2.77759487 |
| 79 | positive regulation of vasculogenesis (GO:2001214) | 2.77551874 |
| 80 | regulation of prostaglandin secretion (GO:0032306) | 2.75256893 |
| 81 | myoblast fusion (GO:0007520) | 2.75216225 |
| 82 | muscle cell fate commitment (GO:0042693) | 2.75177574 |
| 83 | skeletal muscle tissue regeneration (GO:0043403) | 2.74660235 |
| 84 | response to inactivity (GO:0014854) | 2.73907850 |
| 85 | embryonic viscerocranium morphogenesis (GO:0048703) | 2.73653485 |
| 86 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.73636443 |
| 87 | negative regulation of fatty acid transport (GO:2000192) | 2.73382091 |
| 88 | negative regulation of mast cell activation (GO:0033004) | 2.68872372 |
| 89 | positive regulation of myoblast differentiation (GO:0045663) | 2.68816932 |
| 90 | Golgi to plasma membrane protein transport (GO:0043001) | 2.68713872 |
| 91 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.68521739 |
| 92 | negative regulation of lipase activity (GO:0060192) | 2.67500455 |
| 93 | neuromuscular synaptic transmission (GO:0007274) | 2.65089050 |
| 94 | positive regulation of positive chemotaxis (GO:0050927) | 2.64574480 |
| 95 | cullin deneddylation (GO:0010388) | 2.64202524 |
| 96 | peptidyl-proline hydroxylation (GO:0019511) | 2.63955078 |
| 97 | natural killer cell differentiation (GO:0001779) | 2.62132979 |
| 98 | regulation of dendritic spine development (GO:0060998) | 2.60882025 |
| 99 | multicellular organism reproduction (GO:0032504) | 2.60578695 |
| 100 | keratinocyte proliferation (GO:0043616) | 2.59276944 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 5.67849384 |
| 2 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 5.38549519 |
| 3 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.04321260 |
| 4 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.03071809 |
| 5 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 3.00066415 |
| 6 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.82542783 |
| 7 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 2.75107067 |
| 8 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.73213964 |
| 9 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.52096864 |
| 10 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 2.46740038 |
| 11 | BRD4_25478319_ChIP-Seq_HGPS_Human | 2.44392137 |
| 12 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.42554813 |
| 13 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.40934117 |
| 14 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 2.37147736 |
| 15 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.28701247 |
| 16 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 2.24129045 |
| 17 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.20974924 |
| 18 | CJUN_26792858_Chip-Seq_BT549_Human | 2.20526786 |
| 19 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.16096063 |
| 20 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.14783261 |
| 21 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.06856400 |
| 22 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.99539812 |
| 23 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.94214007 |
| 24 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.93918785 |
| 25 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.90630785 |
| 26 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.86678166 |
| 27 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.86156875 |
| 28 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.85757573 |
| 29 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.85657150 |
| 30 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.82067540 |
| 31 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.77289961 |
| 32 | TP53_16413492_ChIP-PET_HCT116_Human | 1.75379327 |
| 33 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.70016787 |
| 34 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.67985325 |
| 35 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.67985325 |
| 36 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.62282135 |
| 37 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.59927313 |
| 38 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.58396676 |
| 39 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.56661330 |
| 40 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.55851613 |
| 41 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.54012448 |
| 42 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.53662791 |
| 43 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.51624799 |
| 44 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.51492149 |
| 45 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.48791719 |
| 46 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.47414582 |
| 47 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.46144669 |
| 48 | P300_19829295_ChIP-Seq_ESCs_Human | 1.45563009 |
| 49 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.44354339 |
| 50 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.42250201 |
| 51 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.36079490 |
| 52 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.36079490 |
| 53 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.35455572 |
| 54 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.34611810 |
| 55 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.31623163 |
| 56 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.31134664 |
| 57 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.29696447 |
| 58 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.25306443 |
| 59 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.24370025 |
| 60 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.23250059 |
| 61 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.22333180 |
| 62 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.22141290 |
| 63 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.20607254 |
| 64 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.19494651 |
| 65 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.19160051 |
| 66 | STAT3_23295773_ChIP-Seq_U87_Human | 1.16363831 |
| 67 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.15574714 |
| 68 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.09868071 |
| 69 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.07960590 |
| 70 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.06037147 |
| 71 | VDR_22108803_ChIP-Seq_LS180_Human | 1.04837337 |
| 72 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.04710066 |
| 73 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.03438692 |
| 74 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02752363 |
| 75 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.02662350 |
| 76 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.02071969 |
| 77 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.01970303 |
| 78 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.01247197 |
| 79 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.97548373 |
| 80 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.96801264 |
| 81 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.96445173 |
| 82 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.95413053 |
| 83 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.94056684 |
| 84 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.93911121 |
| 85 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.93621737 |
| 86 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.93576007 |
| 87 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.92360597 |
| 88 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.92085799 |
| 89 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.91963533 |
| 90 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.91963533 |
| 91 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.89063893 |
| 92 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.88198238 |
| 93 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.87399532 |
| 94 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.87399532 |
| 95 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.84920877 |
| 96 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.84560034 |
| 97 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.84249956 |
| 98 | FUS_26573619_Chip-Seq_HEK293_Human | 0.83846801 |
| 99 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83424000 |
| 100 | TBL1_22424771_ChIP-Seq_293T_Human | 0.83375404 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003950_abnormal_plasma_membrane | 8.67331322 |
| 2 | MP0004145_abnormal_muscle_electrophysio | 6.78443019 |
| 3 | MP0008438_abnormal_cutaneous_collagen | 4.68100882 |
| 4 | MP0003011_delayed_dark_adaptation | 4.62723996 |
| 5 | MP0000749_muscle_degeneration | 4.15883743 |
| 6 | MP0004270_analgesia | 3.69372134 |
| 7 | MP0000372_irregular_coat_pigmentation | 3.44572468 |
| 8 | MP0000747_muscle_weakness | 2.92351797 |
| 9 | MP0004233_abnormal_muscle_weight | 2.69406266 |
| 10 | MP0001299_abnormal_eye_distance/ | 2.64000624 |
| 11 | MP0005275_abnormal_skin_tensile | 2.43116748 |
| 12 | MP0004084_abnormal_cardiac_muscle | 2.34346309 |
| 13 | MP0003279_aneurysm | 2.12162344 |
| 14 | MP0001661_extended_life_span | 2.06967331 |
| 15 | MP0000759_abnormal_skeletal_muscle | 2.03420037 |
| 16 | MP0005623_abnormal_meninges_morphology | 1.82658307 |
| 17 | MP0004272_abnormal_basement_membrane | 1.75249755 |
| 18 | MP0000750_abnormal_muscle_regeneration | 1.72748418 |
| 19 | MP0000751_myopathy | 1.71338950 |
| 20 | MP0010030_abnormal_orbit_morphology | 1.70502790 |
| 21 | MP0009780_abnormal_chondrocyte_physiolo | 1.66819795 |
| 22 | MP0004036_abnormal_muscle_relaxation | 1.66816881 |
| 23 | MP0002933_joint_inflammation | 1.61549882 |
| 24 | MP0005360_urolithiasis | 1.59771432 |
| 25 | MP0002269_muscular_atrophy | 1.55467998 |
| 26 | MP0002106_abnormal_muscle_physiology | 1.54550371 |
| 27 | MP0001879_abnormal_lymphatic_vessel | 1.39902891 |
| 28 | MP0003828_pulmonary_edema | 1.39191262 |
| 29 | MP0003705_abnormal_hypodermis_morpholog | 1.38521811 |
| 30 | MP0002295_abnormal_pulmonary_circulatio | 1.36019746 |
| 31 | MP0003646_muscle_fatigue | 1.35979723 |
| 32 | MP0003045_fibrosis | 1.35178123 |
| 33 | MP0004087_abnormal_muscle_fiber | 1.33689846 |
| 34 | MP0003436_decreased_susceptibility_to | 1.30486233 |
| 35 | MP0005369_muscle_phenotype | 1.29164987 |
| 36 | MP0002837_dystrophic_cardiac_calcinosis | 1.25318877 |
| 37 | MP0009384_cardiac_valve_regurgitation | 1.25276369 |
| 38 | MP0005023_abnormal_wound_healing | 1.20830173 |
| 39 | MP0003186_abnormal_redox_activity | 1.20363958 |
| 40 | MP0005620_abnormal_muscle_contractility | 1.18066710 |
| 41 | MP0000733_abnormal_muscle_development | 1.17038900 |
| 42 | MP0000685_abnormal_immune_system | 1.14068580 |
| 43 | MP0002108_abnormal_muscle_morphology | 1.13031752 |
| 44 | MP0004215_abnormal_myocardial_fiber | 1.12765229 |
| 45 | MP0003091_abnormal_cell_migration | 1.02354133 |
| 46 | MP0009250_abnormal_appendicular_skeleto | 1.01222689 |
| 47 | MP0005367_renal/urinary_system_phenotyp | 0.99587740 |
| 48 | MP0000516_abnormal_urinary_system | 0.99587740 |
| 49 | MP0000569_abnormal_digit_pigmentation | 0.98872373 |
| 50 | MP0005595_abnormal_vascular_smooth | 0.96524105 |
| 51 | MP0002972_abnormal_cardiac_muscle | 0.92432505 |
| 52 | MP0001958_emphysema | 0.91521536 |
| 53 | MP0000538_abnormal_urinary_bladder | 0.91023286 |
| 54 | MP0002166_altered_tumor_susceptibility | 0.91001455 |
| 55 | MP0002168_other_aberrant_phenotype | 0.90735876 |
| 56 | MP0010368_abnormal_lymphatic_system | 0.89635075 |
| 57 | MP0002332_abnormal_exercise_endurance | 0.87845078 |
| 58 | MP0000013_abnormal_adipose_tissue | 0.84875684 |
| 59 | MP0006054_spinal_hemorrhage | 0.83870025 |
| 60 | MP0002006_tumorigenesis | 0.83263596 |
| 61 | MP0005330_cardiomyopathy | 0.78990266 |
| 62 | MP0005503_abnormal_tendon_morphology | 0.77672465 |
| 63 | MP0004484_altered_response_of | 0.75429344 |
| 64 | MP0000767_abnormal_smooth_muscle | 0.73754558 |
| 65 | MP0000003_abnormal_adipose_tissue | 0.70829458 |
| 66 | MP0001542_abnormal_bone_strength | 0.70533216 |
| 67 | MP0002734_abnormal_mechanical_nocicepti | 0.69506526 |
| 68 | MP0005164_abnormal_response_to | 0.69207275 |
| 69 | MP0009697_abnormal_copulation | 0.69148065 |
| 70 | MP0008775_abnormal_heart_ventricle | 0.66779672 |
| 71 | MP0001533_abnormal_skeleton_physiology | 0.66757550 |
| 72 | MP0000163_abnormal_cartilage_morphology | 0.64870811 |
| 73 | MP0004883_abnormal_blood_vessel | 0.61673182 |
| 74 | MP0000230_abnormal_systemic_arterial | 0.61228286 |
| 75 | MP0002234_abnormal_pharynx_morphology | 0.61200980 |
| 76 | MP0003566_abnormal_cell_adhesion | 0.60386034 |
| 77 | MP0005395_other_phenotype | 0.59546332 |
| 78 | MP0005390_skeleton_phenotype | 0.58932998 |
| 79 | MP0003221_abnormal_cardiomyocyte_apopto | 0.57911584 |
| 80 | MP0005508_abnormal_skeleton_morphology | 0.57496221 |
| 81 | MP0002876_abnormal_thyroid_physiology | 0.55301832 |
| 82 | MP0001348_abnormal_lacrimal_gland | 0.55098877 |
| 83 | MP0005253_abnormal_eye_physiology | 0.54268250 |
| 84 | MP0001881_abnormal_mammary_gland | 0.51875964 |
| 85 | MP0002060_abnormal_skin_morphology | 0.51480788 |
| 86 | MP0003959_abnormal_lean_body | 0.51454492 |
| 87 | MP0010234_abnormal_vibrissa_follicle | 0.50653669 |
| 88 | MP0005375_adipose_tissue_phenotype | 0.50240882 |
| 89 | MP0002114_abnormal_axial_skeleton | 0.49599372 |
| 90 | MP0001986_abnormal_taste_sensitivity | 0.48528485 |
| 91 | MP0001764_abnormal_homeostasis | 0.48126538 |
| 92 | MP0008260_abnormal_autophagy | 0.47947909 |
| 93 | MP0001544_abnormal_cardiovascular_syste | 0.47638782 |
| 94 | MP0005385_cardiovascular_system_phenoty | 0.47638782 |
| 95 | MP0010352_gastrointestinal_tract_polyps | 0.47413290 |
| 96 | MP0005171_absent_coat_pigmentation | 0.47397774 |
| 97 | MP0005451_abnormal_body_composition | 0.44547781 |
| 98 | MP0003137_abnormal_impulse_conducting | 0.43282061 |
| 99 | MP0005084_abnormal_gallbladder_morpholo | 0.43280643 |
| 100 | MP0001501_abnormal_sleep_pattern | 0.42529618 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatigable weakness (HP:0003473) | 8.28692345 |
| 2 | Abnormality of the neuromuscular junction (HP:0003398) | 8.28692345 |
| 3 | Popliteal pterygium (HP:0009756) | 7.86456495 |
| 4 | Weak cry (HP:0001612) | 7.23980165 |
| 5 | Amniotic constriction ring (HP:0009775) | 6.82475379 |
| 6 | Abnormality of placental membranes (HP:0011409) | 6.82475379 |
| 7 | Easy fatigability (HP:0003388) | 5.85706263 |
| 8 | Fetal akinesia sequence (HP:0001989) | 5.58811487 |
| 9 | Nemaline bodies (HP:0003798) | 5.43079935 |
| 10 | Gowers sign (HP:0003391) | 5.38990028 |
| 11 | Mesomelia (HP:0003027) | 4.78400700 |
| 12 | Nonprogressive disorder (HP:0003680) | 4.73496720 |
| 13 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.71223152 |
| 14 | Aplasia of the musculature (HP:0100854) | 4.69616731 |
| 15 | Muscle fiber inclusion bodies (HP:0100299) | 4.54159388 |
| 16 | Hypoplastic ischia (HP:0003175) | 4.48413897 |
| 17 | Long clavicles (HP:0000890) | 4.32489700 |
| 18 | Bell-shaped thorax (HP:0001591) | 4.28511924 |
| 19 | Wrist flexion contracture (HP:0001239) | 4.18480887 |
| 20 | Fibular aplasia (HP:0002990) | 4.17648836 |
| 21 | Microglossia (HP:0000171) | 4.09887917 |
| 22 | Decreased muscle mass (HP:0003199) | 3.99784754 |
| 23 | Abnormality of the ischium (HP:0003174) | 3.79797878 |
| 24 | Malignant hyperthermia (HP:0002047) | 3.72600905 |
| 25 | Pterygium (HP:0001059) | 3.71324942 |
| 26 | Absent phalangeal crease (HP:0006109) | 3.67420690 |
| 27 | Akinesia (HP:0002304) | 3.49740611 |
| 28 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 3.32665004 |
| 29 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 3.27839578 |
| 30 | Abnormal finger flexion creases (HP:0006143) | 2.99769865 |
| 31 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.96294621 |
| 32 | Delayed gross motor development (HP:0002194) | 2.95176204 |
| 33 | Dyschromatopsia (HP:0007641) | 2.89262146 |
| 34 | Exercise-induced muscle cramps (HP:0003710) | 2.68940113 |
| 35 | Type 1 muscle fiber predominance (HP:0003803) | 2.59494931 |
| 36 | Calf muscle hypertrophy (HP:0008981) | 2.56195531 |
| 37 | Thin ribs (HP:0000883) | 2.53545704 |
| 38 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.51521322 |
| 39 | Cutaneous melanoma (HP:0012056) | 2.50231994 |
| 40 | Cystic hygroma (HP:0000476) | 2.48287037 |
| 41 | Arthrogryposis multiplex congenita (HP:0002804) | 2.47516998 |
| 42 | Exercise-induced myalgia (HP:0003738) | 2.37778153 |
| 43 | Short palpebral fissure (HP:0012745) | 2.24568726 |
| 44 | Bulbar palsy (HP:0001283) | 2.18561149 |
| 45 | Rhabdomyolysis (HP:0003201) | 2.17534416 |
| 46 | Abnormality of the calf musculature (HP:0001430) | 2.09390505 |
| 47 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.03249292 |
| 48 | Type 2 muscle fiber atrophy (HP:0003554) | 11.1787864 |
| 49 | Muscle fiber atrophy (HP:0100295) | 10.0270001 |
| 50 | Entropion (HP:0000621) | 1.98174241 |
| 51 | Hypoplastic iliac wings (HP:0002866) | 1.97231826 |
| 52 | Aortic dissection (HP:0002647) | 1.96470398 |
| 53 | Metaphyseal dysplasia (HP:0100255) | 1.94247629 |
| 54 | Depressed nasal tip (HP:0000437) | 1.93878196 |
| 55 | Neck muscle weakness (HP:0000467) | 1.91510427 |
| 56 | Subaortic stenosis (HP:0001682) | 1.89085401 |
| 57 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.89085401 |
| 58 | Abnormality of the pubic bones (HP:0003172) | 1.87515422 |
| 59 | Generalized muscle weakness (HP:0003324) | 1.84330678 |
| 60 | Round ear (HP:0100830) | 1.83027649 |
| 61 | Hyporeflexia of lower limbs (HP:0002600) | 1.77373327 |
| 62 | Poor suck (HP:0002033) | 1.75861482 |
| 63 | Myoglobinuria (HP:0002913) | 1.75466250 |
| 64 | Hypoplastic heart (HP:0001961) | 1.73338628 |
| 65 | Rhizomelia (HP:0008905) | 1.72339996 |
| 66 | Diminished movement (HP:0002374) | 1.71151338 |
| 67 | Spondylolisthesis (HP:0003302) | 1.70627008 |
| 68 | Abnormality of the wing of the ilium (HP:0011867) | 1.64845852 |
| 69 | Ovoid vertebral bodies (HP:0003300) | 1.63341229 |
| 70 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.61488115 |
| 71 | Muscle stiffness (HP:0003552) | 1.60648054 |
| 72 | Ulnar deviation of the wrist (HP:0003049) | 1.57649973 |
| 73 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.53802863 |
| 74 | Distal arthrogryposis (HP:0005684) | 1.53766132 |
| 75 | Lipoatrophy (HP:0100578) | 1.53239670 |
| 76 | Hypoplastic scapulae (HP:0000882) | 1.52507184 |
| 77 | Aplasia/Hypoplasia of the scapulae (HP:0006713) | 1.52507184 |
| 78 | Abnormality of the alveolar ridges (HP:0006477) | 1.51724776 |
| 79 | Hematochezia (HP:0002573) | 1.51083059 |
| 80 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 1.49781808 |
| 81 | Hypoplasia of the iris (HP:0007676) | 1.48138451 |
| 82 | Asymmetry of the thorax (HP:0001555) | 1.43068532 |
| 83 | Fatigue (HP:0012378) | 1.42790536 |
| 84 | Cervical subluxation (HP:0003308) | 1.40805448 |
| 85 | Recurrent corneal erosions (HP:0000495) | 1.40091634 |
| 86 | Bone cyst (HP:0012062) | 1.39257454 |
| 87 | Dislocated radial head (HP:0003083) | 1.38618070 |
| 88 | Webbed neck (HP:0000465) | 1.38216994 |
| 89 | Vascular tortuosity (HP:0004948) | 1.36465439 |
| 90 | Sudden death (HP:0001699) | 1.36002239 |
| 91 | Aortic aneurysm (HP:0004942) | 1.35573253 |
| 92 | Soft skin (HP:0000977) | 1.34153402 |
| 93 | Progressive macrocephaly (HP:0004481) | 1.33594258 |
| 94 | Arterial tortuosity (HP:0005116) | 1.32927209 |
| 95 | Poikiloderma (HP:0001029) | 1.32637391 |
| 96 | Abnormality of the intrinsic pathway (HP:0010989) | 1.32387631 |
| 97 | Abnormality of the radial head (HP:0003995) | 1.32379029 |
| 98 | Premature rupture of membranes (HP:0001788) | 1.31773402 |
| 99 | Increased corneal curvature (HP:0100692) | 1.31562479 |
| 100 | Keratoconus (HP:0000563) | 1.31562479 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK24 | 3.59074190 |
| 2 | MAP4K2 | 3.34550709 |
| 3 | MAP3K12 | 2.75701328 |
| 4 | FRK | 2.44505353 |
| 5 | LIMK1 | 2.35955365 |
| 6 | MUSK | 14.5363293 |
| 7 | OBSCN | 1.61475593 |
| 8 | ILK | 1.61021242 |
| 9 | DDR2 | 1.60825776 |
| 10 | MAPKAPK3 | 1.37759377 |
| 11 | MYLK | 1.08088639 |
| 12 | TRPM7 | 1.04526277 |
| 13 | CCNB1 | 0.99658805 |
| 14 | EIF2AK3 | 0.96362001 |
| 15 | PLK2 | 0.93566537 |
| 16 | MELK | 0.82527962 |
| 17 | FGFR2 | 0.79365031 |
| 18 | NLK | 0.75168335 |
| 19 | CLK1 | 0.74685119 |
| 20 | TYK2 | 0.72565086 |
| 21 | PIK3CG | 0.70264262 |
| 22 | EIF2AK1 | 0.68468943 |
| 23 | NUAK1 | 0.67103355 |
| 24 | FER | 0.63331670 |
| 25 | SGK3 | 0.58397661 |
| 26 | JAK1 | 0.53792134 |
| 27 | CDK8 | 0.52349737 |
| 28 | STK39 | 0.52274502 |
| 29 | PRKD3 | 0.51573471 |
| 30 | PAK3 | 0.51044127 |
| 31 | PHKG2 | 0.50408668 |
| 32 | PHKG1 | 0.50408668 |
| 33 | MAPK12 | 0.50039845 |
| 34 | MAP3K5 | 0.49199249 |
| 35 | BCKDK | 0.49127431 |
| 36 | VRK2 | 0.48335896 |
| 37 | CAMK1D | 0.46971949 |
| 38 | CAMKK2 | 0.46732168 |
| 39 | ROCK1 | 0.45510840 |
| 40 | MAPK13 | 0.44579896 |
| 41 | TAOK3 | 0.44035331 |
| 42 | OXSR1 | 0.43374166 |
| 43 | FGFR3 | 0.42197714 |
| 44 | FGFR1 | 0.40605257 |
| 45 | PAK2 | 0.40354136 |
| 46 | PIK3CA | 0.39748563 |
| 47 | PRKCQ | 0.39725994 |
| 48 | SGK2 | 0.39616314 |
| 49 | PLK3 | 0.39162655 |
| 50 | TESK1 | 0.35475031 |
| 51 | STK3 | 0.35416843 |
| 52 | SIK3 | 0.34881186 |
| 53 | MARK3 | 0.32929299 |
| 54 | NEK9 | 0.32480163 |
| 55 | EEF2K | 0.32446257 |
| 56 | CSNK1A1L | 0.32223771 |
| 57 | IRAK3 | 0.30791980 |
| 58 | CAMK1G | 0.30348728 |
| 59 | TRIM28 | 0.29445510 |
| 60 | DAPK1 | 0.27835001 |
| 61 | DMPK | 0.27072370 |
| 62 | CAMK2D | 0.26820121 |
| 63 | MAPK11 | 0.25070413 |
| 64 | TGFBR2 | 0.24881918 |
| 65 | GRK1 | 0.24715607 |
| 66 | MAP3K9 | 0.24622658 |
| 67 | ROCK2 | 0.24102397 |
| 68 | IKBKB | 0.23622601 |
| 69 | AKT2 | 0.23495194 |
| 70 | MAP3K10 | 0.22761452 |
| 71 | PINK1 | 0.22448650 |
| 72 | ABL1 | 0.22438195 |
| 73 | INSRR | 0.22431880 |
| 74 | STK4 | 0.22064346 |
| 75 | DAPK3 | 0.21723206 |
| 76 | NEK1 | 0.21364057 |
| 77 | INSR | 0.21247044 |
| 78 | LATS1 | 0.20984372 |
| 79 | TAF1 | 0.20886484 |
| 80 | ERBB3 | 0.20423718 |
| 81 | MAP3K3 | 0.20322979 |
| 82 | PAK4 | 0.20059993 |
| 83 | AKT3 | 0.19430973 |
| 84 | MOS | 0.18827874 |
| 85 | BMPR1B | 0.18679579 |
| 86 | ADRBK2 | 0.18589172 |
| 87 | PIM1 | 0.17865224 |
| 88 | CAMK1 | 0.17490107 |
| 89 | CSNK1G1 | 0.15889876 |
| 90 | VRK1 | 0.15801064 |
| 91 | CAMK4 | 0.14982656 |
| 92 | PRKCE | 0.14683739 |
| 93 | HCK | 0.14225638 |
| 94 | BUB1 | 0.13705186 |
| 95 | JAK3 | 0.12958159 |
| 96 | ZAP70 | 0.12789741 |
| 97 | PRKG1 | 0.12125489 |
| 98 | MAPKAPK5 | 0.10404526 |
| 99 | CSNK1G2 | 0.10055013 |
| 100 | ADRBK1 | 0.09921956 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Mineral absorption_Homo sapiens_hsa04978 | 4.31253712 |
| 2 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 3.53219196 |
| 3 | Circadian rhythm_Homo sapiens_hsa04710 | 3.49976765 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.43734147 |
| 5 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 3.26700617 |
| 6 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.18947013 |
| 7 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 3.18784777 |
| 8 | Selenocompound metabolism_Homo sapiens_hsa00450 | 3.09202483 |
| 9 | Proteasome_Homo sapiens_hsa03050 | 2.78116818 |
| 10 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.28536588 |
| 11 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.21386692 |
| 12 | Protein export_Homo sapiens_hsa03060 | 2.17836388 |
| 13 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.16155083 |
| 14 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.02154522 |
| 15 | Viral myocarditis_Homo sapiens_hsa05416 | 1.93403275 |
| 16 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.80380278 |
| 17 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.71908037 |
| 18 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.70331370 |
| 19 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.70004000 |
| 20 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.49928120 |
| 21 | Asthma_Homo sapiens_hsa05310 | 1.35224318 |
| 22 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.29121004 |
| 23 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.27297994 |
| 24 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.26472089 |
| 25 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.15041793 |
| 26 | Focal adhesion_Homo sapiens_hsa04510 | 1.11322745 |
| 27 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.09131659 |
| 28 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.04957956 |
| 29 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.03926822 |
| 30 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.03910044 |
| 31 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.00284436 |
| 32 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.99298530 |
| 33 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.99015154 |
| 34 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.98718427 |
| 35 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.93731016 |
| 36 | Galactose metabolism_Homo sapiens_hsa00052 | 0.92527278 |
| 37 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.91014597 |
| 38 | Legionellosis_Homo sapiens_hsa05134 | 0.89800429 |
| 39 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.89678162 |
| 40 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.86777786 |
| 41 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.86701674 |
| 42 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.84625935 |
| 43 | Tight junction_Homo sapiens_hsa04530 | 0.83629244 |
| 44 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.82047831 |
| 45 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.81466980 |
| 46 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.80379956 |
| 47 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.77529530 |
| 48 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.76586464 |
| 49 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.75796531 |
| 50 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.73724069 |
| 51 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.72989926 |
| 52 | Melanoma_Homo sapiens_hsa05218 | 0.70770803 |
| 53 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70224427 |
| 54 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.69805285 |
| 55 | Insulin resistance_Homo sapiens_hsa04931 | 0.69233849 |
| 56 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.67555239 |
| 57 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.66833306 |
| 58 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.64903604 |
| 59 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.64040601 |
| 60 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.62901478 |
| 61 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.62015687 |
| 62 | RNA degradation_Homo sapiens_hsa03018 | 0.61976901 |
| 63 | Allograft rejection_Homo sapiens_hsa05330 | 0.61858670 |
| 64 | Adherens junction_Homo sapiens_hsa04520 | 0.61855758 |
| 65 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.56471820 |
| 66 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.53902090 |
| 67 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.52209612 |
| 68 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.50835808 |
| 69 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.50530502 |
| 70 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.50422115 |
| 71 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.49110064 |
| 72 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.48933744 |
| 73 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.47651601 |
| 74 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.47156755 |
| 75 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.46834560 |
| 76 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.46741723 |
| 77 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.46051034 |
| 78 | Peroxisome_Homo sapiens_hsa04146 | 0.43971868 |
| 79 | Alzheimers disease_Homo sapiens_hsa05010 | 0.42131464 |
| 80 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.41823074 |
| 81 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.41237927 |
| 82 | Histidine metabolism_Homo sapiens_hsa00340 | 0.39693157 |
| 83 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.39515444 |
| 84 | Parkinsons disease_Homo sapiens_hsa05012 | 0.38716444 |
| 85 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.38664136 |
| 86 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.38539107 |
| 87 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.37525673 |
| 88 | Phototransduction_Homo sapiens_hsa04744 | 0.37147884 |
| 89 | Basal transcription factors_Homo sapiens_hsa03022 | 0.36493975 |
| 90 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.35788526 |
| 91 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.35520576 |
| 92 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.33895330 |
| 93 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.33731827 |
| 94 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.27879814 |
| 95 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.24305174 |
| 96 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.23662351 |
| 97 | Endocytosis_Homo sapiens_hsa04144 | 0.21712936 |
| 98 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.21382113 |
| 99 | Retinol metabolism_Homo sapiens_hsa00830 | 0.21299696 |
| 100 | Huntingtons disease_Homo sapiens_hsa05016 | 0.20891228 |

